Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer (Q72516643)
Jump to navigation
Jump to search
scientific article published on 01 February 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer |
scientific article published on 01 February 1995 |
Statements
Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer (English)
B Chevallier
P Fumoleau
P Kerbrat
V Dieras
H Roche
I Krakowski
N Azli
M Bayssas
M A Lentz
1 February 1995